$3,635.35 travel Payment -- Gilead Sciences to Dr. Catherine Morris

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Gilead Sciences made a $3.6K travel payment to Catherine Morris, a Pulmonology specialist in City, MN. The payment was associated with Tecfidera. The payment of $3,635.35 to Dr. Catherine Morris by Gilead Sciences in March 2026 was for travel and lodging related to Tecfidera. This payment represents a moderate financial interaction between the pharma company and a pulmonologist. The specific nature of the travel and lodging is not detailed, but it is associated with a specific drug.

Patient Guidance: What This Payment Means for You

If you are a patient, this payment indicates your doctor may have received support for travel and lodging expenses from a pharmaceutical company, which could be related to educational events or research. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

While travel and lodging payments are common in the pharmaceutical industry, the association of a pulmonologist with Tecfidera (a multiple sclerosis drug) and the placeholder location warrants further investigation into the specific context of this payment.

Regulatory Context: Sunshine Act Requirements

Payments made by manufacturers to physicians for travel and lodging are subject to disclosure under the Sunshine Act (part of the Affordable Care Act) to ensure transparency in financial relationships.

Related Topics

This payment is related to the following healthcare transparency topics:

• gilead-sciences
• travel-and-lodging
• pulmonology
• tecfidera
• physician-payment
• open-payments

Understanding travel Payments

Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.

Frequently Asked Questions About This Payment

What was this $3.6K payment for?

This was a travel payment of $3.6K from Gilead Sciences to Catherine Morris, categorized as "Travel and Lodging". It was associated with Tecfidera. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Catherine Morris accept pharmaceutical money?

Yes, Catherine Morris received this $3.6K payment from Gilead Sciences. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Catherine Morris's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this travel payment?

A travel payment of $3.6K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Pulmonology?

To compare this payment against Pulmonology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Pulmonology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Catherine Morris's relationship with Gilead Sciences?

The payment date is in the future (2026), suggesting it may be pre-booked or an estimate. This $3.6K travel payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Pulmonology?

The payment ID 'OP-MNIOIJS0-HTAWQG' is a unique identifier for this specific transaction.

What should patients do after learning about this payment?

If you are a patient, this payment indicates your doctor may have received support for travel and lodging expenses from a pharmaceutical company, which could be related to educational events or research.

What else should I know about this travel payment?

Tecfidera is a drug used to treat multiple sclerosis, not typically associated with pulmonology.

Related Reports

• View Dr. Catherine Morris's full payment report
• Gilead Sciences full spending report
• Browse all Pulmonology payments
• Browse all payments in Minnesota
• Search for other payments